Blood Groups, Rh Factor, Transfusion Rules, and Immunity — Complete Biology Notes
Study notes on ABO blood group system, Rh factor, blood transfusion compatibility, antigens and antibodies, types of immunity, and vaccination schedule for Kerala PSC.
Study notes on ABO blood group system, Rh factor, blood transfusion compatibility, antigens and antibodies, types of immunity, and vaccination schedule for Kerala PSC.
Sign in to continue reading
You've read 5 free study notes. Sign in to unlock all 270+ notes.
Free forever — no payment needed for study notes.
Or
Blood groups and immunity are high-frequency topics in Kerala PSC exams. This note covers the ABO system, Rh factor, transfusion rules, types of immunity, and the Indian vaccination schedule.
ABO Blood Group System
Discovered by Karl Landsteiner in 1900 (Nobel Prize in Physiology/Medicine, 1930).
Antigens and Antibodies
| Blood Group | Antigen on RBC | Antibody in Plasma | Genotype |
|---|---|---|---|
| A | A | Anti-B | IA IA or IA i |
| B | B | Anti-A | IB IB or IB i |
| AB | A and B | None | IA IB |
| O | None | Anti-A and Anti-B | ii |
Key Points:
- Antigens are proteins on the surface of red blood cells
- Antibodies are proteins in the plasma that attack foreign antigens
- Blood group is determined by co-dominant alleles (IA and IB are co-dominant; i is recessive)
Blood Group Inheritance
| Parent 1 | Parent 2 | Possible Children |
|---|---|---|
| A x A | — | A or O |
| A x B | — | A, B, AB, or O |
| A x AB | — | A, B, or AB |
| A x O | — | A or O |
| B x B | — | B or O |
| B x AB | — | A, B, or AB |
| B x O | — | B or O |
| AB x AB | — | A, B, or AB (never O) |
| AB x O | — | A or B (never AB or O) |
| O x O | — | O only |
Rh Factor
Discovered by Landsteiner and Wiener in 1940 using Rhesus monkey blood.
| Rh Type | Antigen | Frequency in India |
|---|---|---|
| Rh+ (Positive) | Rh antigen (D antigen) present | ~95% of Indians |
| Rh- (Negative) | Rh antigen absent | ~5% of Indians |
Erythroblastosis Fetalis (Rh Incompatibility)
| Aspect | Detail |
|---|---|
| Occurs when | Rh-negative mother carries Rh-positive foetus (second pregnancy) |
| Mechanism | Mother develops anti-Rh antibodies after first pregnancy; these cross placenta in subsequent pregnancy |
| Effect | Destruction of foetal RBCs (haemolytic disease of newborn) |
| Prevention | RhoGAM injection (anti-D immunoglobulin) given to Rh- mother within 72 hours of first delivery |
Blood Transfusion Compatibility
Who Can Donate to Whom?
| Donor Group | Can Donate To |
|---|---|
| O- | All groups (Universal Donor) |
| O+ | O+, A+, B+, AB+ |
| A- | A-, A+, AB-, AB+ |
| A+ | A+, AB+ |
| B- | B-, B+, AB-, AB+ |
| B+ | B+, AB+ |
| AB- | AB-, AB+ |
| AB+ | AB+ only |
Who Can Receive from Whom?
| Recipient Group | Can Receive From |
|---|---|
| AB+ | All groups (Universal Recipient) |
| AB- | AB-, A-, B-, O- |
| A+ | A+, A-, O+, O- |
| A- | A-, O- |
| B+ | B+, B-, O+, O- |
| B- | B-, O- |
| O+ | O+, O- |
| O- | O- only |
Key Terms
| Term | Meaning |
|---|---|
| Universal Donor | O- (no antigens, no Rh) |
| Universal Recipient | AB+ (no antibodies, has Rh) |
| Agglutination | Clumping of RBCs when incompatible blood is mixed |
| Cross-matching | Testing donor and recipient blood for compatibility before transfusion |
Blood Components and Facts
| Component | Detail |
|---|---|
| RBC (Erythrocytes) | Carry oxygen; no nucleus in mature RBCs; life span ~120 days |
| WBC (Leucocytes) | Immunity; has nucleus; life span varies (hours to years) |
| Platelets (Thrombocytes) | Blood clotting; life span ~5-9 days |
| Plasma | 55% of blood; contains water, proteins, antibodies |
| Blood volume in adult | ~5-6 litres |
| pH of blood | 7.35-7.45 (slightly alkaline) |
| Blood bank storage | RBCs stored at 4 deg C for up to 42 days |
| Platelets storage | 20-24 deg C with agitation, 5 days |
Types of Immunity
Classification
| Type | Subtype | How Acquired | Duration | Example |
|---|---|---|---|---|
| Innate (Non-specific) | — | Born with it | Lifelong | Skin, mucous membranes, stomach acid, phagocytes |
| Acquired (Adaptive/Specific) | Active — Natural | Body fights infection | Long-lasting | Recovering from chickenpox |
| Acquired | Active — Artificial | Vaccination | Long-lasting | Polio vaccine, COVID vaccine |
| Acquired | Passive — Natural | Mother to child | Temporary (months) | Antibodies via placenta or breast milk (colostrum) |
| Acquired | Passive — Artificial | Pre-formed antibodies injected | Temporary (weeks) | Anti-tetanus serum, anti-venom |
Active vs Passive Immunity
| Feature | Active Immunity | Passive Immunity |
|---|---|---|
| Antibodies produced by | Own body | Received from outside |
| Time to develop | Slow (days to weeks) | Immediate |
| Duration | Long-lasting (memory cells) | Short-lived (weeks to months) |
| Memory cells | Formed | Not formed |
| Example | Vaccination, natural infection | Maternal antibodies, anti-serum |
Antigens and Antibodies
| Feature | Antigen | Antibody (Immunoglobulin) |
|---|---|---|
| Nature | Foreign substance that triggers immune response | Protein produced by B-lymphocytes |
| Also called | Immunogen | Immunoglobulin (Ig) |
| Types of Ig | — | IgG, IgA, IgM, IgE, IgD |
Types of Immunoglobulins
| Ig Type | Key Feature |
|---|---|
| IgG | Most abundant (75%); crosses placenta; secondary immune response |
| IgA | Found in secretions (saliva, tears, breast milk); mucosal immunity |
| IgM | Largest antibody; first to respond (primary immune response) |
| IgE | Allergic reactions; defence against parasites |
| IgD | Found on B-cell surface; least understood |
Indian Vaccination Schedule (National Immunisation Schedule)
| Age | Vaccine | Disease |
|---|---|---|
| At birth | BCG, OPV-0, Hepatitis B birth dose | TB, Polio, Hepatitis B |
| 6 weeks | OPV-1, Pentavalent-1, Rotavirus-1, fIPV-1, PCV-1 | Polio, DPT+HepB+Hib, Rotavirus, Polio (injectable), Pneumococcal |
| 10 weeks | OPV-2, Pentavalent-2, Rotavirus-2 | Same as above |
| 14 weeks | OPV-3, Pentavalent-3, Rotavirus-3, fIPV-2, PCV-2 | Same as above |
| 9 months | MR-1 (Measles-Rubella), PCV booster | Measles, Rubella, Pneumococcal |
| 16-24 months | MR-2, OPV booster, DPT booster-1 | Measles, Polio, DPT |
| 5-6 years | DPT booster-2 | Diphtheria, Pertussis, Tetanus |
| 10 years | TT (Tetanus Toxoid) | Tetanus |
| 16 years | TT | Tetanus |
Key Vaccine Facts
| Vaccine | Type | Developer/Discovery |
|---|---|---|
| BCG | Live attenuated | Albert Calmette and Camille Guerin |
| OPV (Sabin) | Live attenuated (oral) | Albert Sabin |
| IPV (Salk) | Inactivated (injectable) | Jonas Salk |
| Smallpox vaccine | First vaccine ever | Edward Jenner (1796) |
| Rabies vaccine | Killed virus | Louis Pasteur |
Frequently Asked PSC Questions
Q1. Who discovered blood groups? Ans: Karl Landsteiner (1900)
Q2. Which blood group is called the Universal Donor? Ans: O negative (O-)
Q3. Which blood group is the Universal Recipient? Ans: AB positive (AB+)
Q4. What causes erythroblastosis fetalis? Ans: Rh incompatibility between Rh-negative mother and Rh-positive foetus
Q5. Which antibody crosses the placenta? Ans: IgG
Q6. Which is the largest antibody? Ans: IgM
Q7. Who developed the first vaccine? Ans: Edward Jenner (smallpox vaccine, 1796)
Q8. Colostrum provides which type of immunity to the newborn? Ans: Passive natural immunity
Q9. What is the life span of RBCs? Ans: Approximately 120 days
Q10. Which immunoglobulin is involved in allergic reactions? Ans: IgE
Found an error or have a suggestion?